Cost-effectiveness of maternal vaccine and/or monoclonal antibody strategies against respiratory syncytial virus in Belgian infants
Source
npj Vaccines - ISSN 2059-0105-11:1 (2026) p. 1-14
Incidence and costs of hospitalisation due to acute respiratory infection in adults aged over 50 years in Jiangsu, China in 2019-23 : a real-world medical database analysis of 0.2 million episodes
Source
Journal of Global Health - ISSN 2047-2978-15 (2025) p. 1-11
Cost-effectiveness analysis of alternative infant and neonatal rotavirus vaccination schedules in Malawi
Source
PLoS global public health - ISSN 2767-3375-5:4 (2025) p. 1-17
Influential drivers of the cost-effectiveness of respiratory syncytial virus vaccination in European older adults : a multi-country analysis
Source
BMC medicine - ISSN 1741-7015-23:1 (2025) p. 1-17
Management cost of acute respiratory infections in older adults in China : a systematic review and meta-analysis
Source
Journal of Global Health - ISSN 2047-2978-14 (2024) p. 1-10